Project | Construction
CZECRIN_PharmTech
Modernization of technological units
CZECRIN for innovative clinical research.
Project information
Project name: CZECRIN_PHARMTECH
Reg. no: CZ.02.01.01/00/23_015/0008194
Programme: the Johannes Amos Comenius Operational Programme
Duration: 1. 1. 2024 – 31. 12. 2026
Annotation
The CZECRIN_PHARMTECH project is focused on the development and modernisation of the existing technological equipment of the Large Research Infrastructure CZECRIN.
The project activities will be aimed in particular at the acquisition of new and modernisation of the existing infrastructure facilities of the beneficiary and the partner so as to enable the development and improvement of the services provided to users of the infrastructure.
Research capacity for innovative clinical research and drug development through non-commercial clinical trials will be expanded.
News from the construction site
The equipment of individual technological units with instrumentation is being acquired. The acquired equipment is being put into operation and the services that will be offered to users in open access mode are being defined.
The submitted CZECRIN_PHARMTECH project is focused on the development and modernization of the TECHNOLOGY UNITS, specifically the modernization of the already existing GMP units that operate in the Good Manufacturing Practice (GMP) mode and the development of Pharmacology Units that will complement the portfolio of clinical research services offered in the open access mode to the research community.
Modernised GMP units
The implementation of the submitted project will modernize 2 GMP units.
GMP Unit
Centre for Cell and Tissue Engineering (CTEF cGMP)
The unit is located at the LRI CZECRIN partner in St. Anne’s University Hospital in Brno, FNUSA. It is focused on research, development and GMP production of somatic cell medicines, subsequently evaluated in clinical trials, especially within the CZECRIN|ONCO network.
GMP Unit
GMP MU unit
The unit is located within the Masaryk University (MU), Institute of Haematology and Blood Transfusion (IHT). This unit is part of the Institute of Pharmacology of the Masaryk University and is focused on research, development and GMP production of advanced therapeutics (ATMP).
Refined pharmacological units
The implementation of the project will also expand the services of the CZECRIN LRI within 2 Pharmacological Units:
Pharmacological units
Cellular unit
engaged in research in the fields of chemical and cellular pharmacology; the unit consists of the Bioanalytical Laboratory (Department of Pharmacology, Faculty of Medicine, MU), the Psychopharmacological Laboratory (a detached unit of the MU National Institute of Mental Health (NIMH) – this unit is part of the Institute of Pharmacology, Faculty of Medicine, MU) and the Molecular Pathophysiological Laboratory (Department of Pathophysiology, Faculty of Medicine, MU).
Pharmacological units
Protein unit
engaged in research of protein characteristics (Loschmidt Laboratory of Protein Engineering, Faculty of Science, MU).
We are modernizing for better clinical research.
Follow us on social media and stay up to date!